Fortune Business Insights, recently introduced a report on Global Anti-obesity Drugs Market Report is an in-depth study providing a complete analysis of the industry for the period 2022 to 2027. It provides a complete overview of the Global industry considering all the major industry trends, market dynamics, and competitive scenarios.
People globally, as well as national economies, rely heavily on the healthcare industry. It is one of the world’s fastest-growing industries. With healthcare spending accounting for more than 10% of most developed countries’ GDP, there is a link between income levels and healthcare spending in different countries.
the statistical and analytical approach that is required for the growth of Anti-obesity Drugs Market for the period 2022 and 2028. The key industrial insights provided in the report gives a better idea about the market overview to the readers regarding the existing scenario in the market. In addition, the report includes detailed discussion on current and future market trends that are associated with the growth of the market.
The market is projected to grow from USD 1,742.5 million in 2020 to USD 3,421.0 million in 2027 at a CAGR of 10.1% in the 2020-2027 period.
Anti-obesity Drugs Market Drivers:
The rapidly increasing population suffering from obesity has led to rising concerns regarding its effective management. For instance, according to the World Obesity Federation, currently, there are 650 million adults and 120 million children dealing with obesity. Moreover, around 2 trillion U.S dollars are spent annually on obesity management. Also, the Centers for Disease Control and Prevention (CDC) estimates the prevalence of obesity at around 42.5% in adults aged 20 and over in the U.S. The growing awareness among patients in emerging nations about the timely management of weight gain is anticipated to increase the demand for anti-obesity drugs and help proliferate its growth during 2020-2027.
Get Sample Report:
What is the aim of the report?
The Anti-obesity Drugs Market report presents the estimated market size of Market by the end of forecast period. Additionally, the historical and current market size is also examined in the report.
Based on various indicators, the Year-on-Year growth (%) and compound annual growth rate (CAGR) for the given forecast period is offered.
An overview of the Market based on geographical scope, market segmentation and financial performance of key players is presented in the report.
The report presents current trends in the industry and future scope of the Market in North America, Asia Pacific, Europe, Latin America and Middle East and Africa.
The various parameters accelerating the growth of Market are incorporated in the research report.
The report analyzes growth rate, market size and valuation of the Market during the forecast period.
What aspects regarding the regional analysis Market are included in this report?
Geographical regions covered in the report include North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The report consists of detailed region-wise analysis of current and future market trends, providing information on product usage and consumption.
The growth rate of the market in every region, including their countries over the forecast period is included in the market report.
Major Anti-obesity Drugs Market Manufacturers covered in the market report include:
- Novo Nordisk (Denmark, Scandinavia)
- GlaxoSmithKline (Brentford, U.K)
- Vivus Pharmaceuticals (California U.S)
- Currax Pharmaceuticals LLC (New Jersey, U.S)
- Pfizer Inc. (New York, U.S)
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Other Players
On the basis of Geography, the Global Anti-obesity Drugs Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a considerable share in the global Animal Feed Enzymes Market. Due to increasing investment for research and development process and adoption of solutions in the region whereas Asia-Pacific is expected to grow at a faster pace during the forecasted period.
|North America||United States, Canada and Mexico|
|Europe||Germany, UK, France, Italy, Russia and Turkey etc.|
|Asia-Pacific||China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc.|
|South America||Brazil, Argentina, Columbia etc.|
|Middle East & Africa||Saudi Arabia, UAE, Egypt, Nigeria and South Africa|
Based on what factors are the key market players assessed in this report?
- The report offers detailed analysis of leading companies in the market across the globe.
- It provides details of the major vendors involved in the Market including Key Players
- A comprehensive overview of each company including the company profile, generated revenue, pricing of goods and the manufactured products is incorporated in the report.
- The facts and figures about market competitors along with standpoints of leading market players are presented in the report.
- The recent developments, mergers and acquisitions related to mentioned key players are provided in the market report.
Reasons to Buy the Report:
- Market Size Forecasts: The authors of the report have provided accurate estimation of the global Anti-obesity Drugs Market size based on value and volume
- Market Trend Analysis: This section of the report throws light on the approaching trends and developments in the global Anti-obesity Drugs Market
- Future Prospects: The report here offers crucial information on the rewarding opportunities in the global Anti-obesity Drugs Market
- Regional Analysis: Inclusive analysis of the potential regions and their countries in the global Anti-obesity Drugs Market is provided in this part of the report
- Segmental Analysis: Here, key segments comprising product type, application, and end user and their contribution to the overall market size are discussed in detail
- Competitive Landscape: Market participants will get an overview of the business strategies considered by their competitors to stay ahead of the curve. This analysis will help the players to make informed business decisions in future.
For more details, Connect with our Analyst: https://www.fortunebusinessinsights.com/enquiry/customization/104783
Table of Content:
1 Market Overview
1.1 Anti-obesity Drugs Market Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
184.108.40.206 United States Market States and Outlook (2020-2026)
220.127.116.11 Canada Market States and Outlook (2020-2026)
18.104.22.168 Mexico Market States and Outlook (2020-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
22.214.171.124 Germany Market States and Outlook (2020-2026)
126.96.36.199 France Market States and Outlook (2020-2026)
188.8.131.52 UK Market States and Outlook (2020-2026)
184.108.40.206 Russia Market States and Outlook (2020-2026)
220.127.116.11 Italy Market States and Outlook (2020-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
18.104.22.168 China Market States and Outlook (2020-2026)
22.214.171.124 Japan Market States and Outlook (2020-2026)
126.96.36.199 Korea Market States and Outlook (2020-2026)
188.8.131.52 India Market States and Outlook (2020-2026)
184.108.40.206 Southeast Asia Market States and Outlook (2020-2026)
1.4.4 South America, Middle East and Africa
220.127.116.11 Brazil Market States and Outlook (2020-2026)
18.104.22.168 Egypt Market States and Outlook (2020-2026)
22.214.171.124 Saudi Arabia Market States and Outlook (2020-2026)
126.96.36.199 South Africa Market States and Outlook (2020-2026)
188.8.131.52 Turkey Market States and Outlook (2020-2026)
1.5 Anti-obesity Drugs Market Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Anti-obesity Drugs Market Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anti-obesity Drugs Market Sales and Market Share by Manufacturer (2020-2026)
3.2 Global Anti-obesity Drugs Market Revenue and Market Share by Manufacturer (2020-2026)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-obesity Drugs Market Manufacturer Market Share in 2020
3.3.2 Top 6 Anti-obesity Drugs Market Manufacturer Market Share in 2020
3.4 Market Competition Trend
4 Global Anti-obesity Drugs Market Market Analysis by Regions
4.1 Global Anti-obesity Drugs Market Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-obesity Drugs Market Sales and Market Share by Regions (2020-2026)
4.1.2 Global Anti-obesity Drugs Market Revenue and Market Share by Regions (2020-2026)
4.2 North America Anti-obesity Drugs Market Sales and Growth Rate (2020-2026)
4.3 Europe Anti-obesity Drugs Market Sales and Growth Rate (2020-2026)
4.4 Asia-Pacific Anti-obesity Drugs Market Sales and Growth Rate (2020-2026)
4.5 South America Anti-obesity Drugs Market Sales and Growth Rate (2020-2026)
4.6 Middle East and Africa Anti-obesity Drugs Market Sales and Growth Rate (2020-2026)
Have Any Query? Ask Our Experts:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Email: [email protected]
Phone: US +1 424 253 0390 / UK +44 2071 939123 / APAC: +91 744 740 1245
Related Reports :